1. Burrell S, MacDonald A. Artifacts and pitfalls in myocardial perfusion imaging. J Nucl Med Technol 2006;34:193-211.
2. Higley B, Smith FW, Smith T, Gemmell HG, Das Gupta P, Gvozdanovic DV, et al. Technetium-99m-1,2-bis[bis(2-ethoxyethyl) phosphino]ethane: Human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. J Nucl Med 1993;34:8-30.
3. Zhao G, Linke A, Xu X, Ochoa M, Belloni F, Belardinelli L, et al. Comparative profile of vasodilation by CVT-3146, a novel A2A receptor agonist, and adenosine in conscious dogs. J Pharmacol Exp Ther 2003;307:182-9.
4. Hendel R, Taillefer R, Widner P, Crane P. Preliminary experience with BMS068645, a selective A2A adenosine agonist, for pharmacologic stress myocardial perfusion imaging. Circulation 2005;112:474.
5. Garnock-Jones KP, Curran MP. Regadenoson. Am J Cardiovasc Drugs 2010;10:65-71.